Sr. Director
Atavistik Bio
Sr. Director
Atavistik Bio
Develops precision allosteric therapeutics for oncology
Salary Range: 270000 to 290000 (Currency: USD) (Pay period: per-year-salary)
Company Summary:
Atavistik Bio is a privately-held clinical stage biotechnology company accelerating the discovery and development of transformative precision allosteric therapeutics to address serious unmet patient needs. Our proprietary AMPS™ platform allows us to rapidly unlock functional cryptic pockets across a broad range of target classes to accelerate the development of groundbreaking medicines. We have rapidly established an emerging pipeline of allosteric therapeutics with the potential to achieve superior efficacy and tolerability profiles by leveraging the power of allostery.
Atavistik Bio is led by an experienced team of drug hunters with a proven track record of developing marketed small molecule therapies and supported by top-tier investors, including The Column Group, Nextech Invest, Lux Capital, Regeneron Ventures, and RA Capital Management.
Develops precision allosteric therapeutics for oncology
Atavistik Bio develops precision allosteric small molecule therapeutics for oncology and rare diseases using its AMPS platform, integrated with an AI-enabled discovery engine. The platform uses metabolites as bait to reveal cryptic allosteric sites on proteins, enabling selective modulation of targets that may be difficult to drug. It differentiates itself by targeting metabolite-protein interactions and pursuing collaborations with larger partners, such as Pfizer, to apply its platform to more targets. The company aims to deliver effective, targeted therapies with favorable safety profiles by advancing its internal pipeline and pursuing strategic partnerships in precision oncology and rare diseases.
Explore more opportunities at Atavistik Bio